| Hiral Harshad Patel, DPT | |
|
13630 Maple Ave, Flushing, NY 11355-3824 | |
| (347) 437-0325 | |
| (866) 202-3177 |
| Full Name | Hiral Harshad Patel |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 13630 Maple Ave, Flushing, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124779137 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081P0010X | Physical Medicine & Rehabilitation - Pediatric Rehabilitation Medicine | 048223 (New York) | Secondary |
| 225100000X | Physical Therapist | 048223 (New York) | Primary |
| Entity Name | Theradynamics Rehab Pt, Ot & Slp, Pllc |
|---|---|
| Entity Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Entity Identifiers | NPI Number: 1912463399 PECOS PAC ID: 4082045802 Enrollment ID: O20200512001530 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the expansion of its global Clinical Logistics Services (CLS) capabilities. A new, state-of-the-art distribution center in Singapore and the recent expansion of the Company's facilities in Billerica, Mass., will help PAREXEL more effectively manage clients' global clinical trial supply requirements.
A new online database will empower researchers exploring how hair follicles and the surrounding skin develop, according to an article published recently in the journal Developmental Cell. The work is central to understanding the interactions between stem cells and their environment - or "niche cells" - during fetal development, and will specifically facilitate future attempts to make skin grafts with functional hair follicles or to regenerate lost hair in patients.
Researchers at the Buck Institute for Age Research have successfully used human induced pluripotent stem cells (iPSCs) to treat rodents afflicted with Parkinson's Disease (PD). The research, which validates a scalable protocol that the same group had previously developed, can be used to manufacture the type of neurons needed to treat the disease and paves the way for the use of iPSC's in various biomedical applications. Results of the research, from the laboratory of Buck faculty Xianmin Zeng, Ph.D., are published August 16, 2010 in the on-line edition of the journal Stem Cells.
What if I were grown only so that my organs could be harvested, and I had to care for others whose organs are being taken, too, while I wait for my own death? What if doctors cut off a piece of the tumor that killed me and grew it in a lab for the next sixty years? What if scientists discovered a gene that would ensure my happiness no matter what life throws at me?
› Verified 1 days ago
| Entity Name | High Line Rehab Pt Pc |
|---|---|
| Entity Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Entity Identifiers | NPI Number: 1659756641 PECOS PAC ID: 6204133861 Enrollment ID: O20200930000194 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the expansion of its global Clinical Logistics Services (CLS) capabilities. A new, state-of-the-art distribution center in Singapore and the recent expansion of the Company's facilities in Billerica, Mass., will help PAREXEL more effectively manage clients' global clinical trial supply requirements.
A new online database will empower researchers exploring how hair follicles and the surrounding skin develop, according to an article published recently in the journal Developmental Cell. The work is central to understanding the interactions between stem cells and their environment - or "niche cells" - during fetal development, and will specifically facilitate future attempts to make skin grafts with functional hair follicles or to regenerate lost hair in patients.
Researchers at the Buck Institute for Age Research have successfully used human induced pluripotent stem cells (iPSCs) to treat rodents afflicted with Parkinson's Disease (PD). The research, which validates a scalable protocol that the same group had previously developed, can be used to manufacture the type of neurons needed to treat the disease and paves the way for the use of iPSC's in various biomedical applications. Results of the research, from the laboratory of Buck faculty Xianmin Zeng, Ph.D., are published August 16, 2010 in the on-line edition of the journal Stem Cells.
What if I were grown only so that my organs could be harvested, and I had to care for others whose organs are being taken, too, while I wait for my own death? What if doctors cut off a piece of the tumor that killed me and grew it in a lab for the next sixty years? What if scientists discovered a gene that would ensure my happiness no matter what life throws at me?
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hiral Harshad Patel, DPT 121 Garrison Ave Apt 102, Jersey City, NJ 07306-5466 Ph: (510) 320-9218 | Hiral Harshad Patel, DPT 13630 Maple Ave, Flushing, NY 11355-3824 Ph: (347) 437-0325 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the expansion of its global Clinical Logistics Services (CLS) capabilities. A new, state-of-the-art distribution center in Singapore and the recent expansion of the Company's facilities in Billerica, Mass., will help PAREXEL more effectively manage clients' global clinical trial supply requirements.
A new online database will empower researchers exploring how hair follicles and the surrounding skin develop, according to an article published recently in the journal Developmental Cell. The work is central to understanding the interactions between stem cells and their environment - or "niche cells" - during fetal development, and will specifically facilitate future attempts to make skin grafts with functional hair follicles or to regenerate lost hair in patients.
Researchers at the Buck Institute for Age Research have successfully used human induced pluripotent stem cells (iPSCs) to treat rodents afflicted with Parkinson's Disease (PD). The research, which validates a scalable protocol that the same group had previously developed, can be used to manufacture the type of neurons needed to treat the disease and paves the way for the use of iPSC's in various biomedical applications. Results of the research, from the laboratory of Buck faculty Xianmin Zeng, Ph.D., are published August 16, 2010 in the on-line edition of the journal Stem Cells.
What if I were grown only so that my organs could be harvested, and I had to care for others whose organs are being taken, too, while I wait for my own death? What if doctors cut off a piece of the tumor that killed me and grew it in a lab for the next sixty years? What if scientists discovered a gene that would ensure my happiness no matter what life throws at me?
› Verified 1 days ago